Cabaletta Bio, Inc.
USD3.04
+0.12 (+4.11%)
CEO
Steven A. Nichtberger
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.90
Prev. Close
$2.92
Day Low
$2.82
Day High
$3.08
52W Low
$1.26
52W High
$4.23
Market Cap
$0.50B
Volume
24.30M
| 22,000 |
| $3.22 |
| 10 Jun 2026 | HENRIQUES RICHARD C JR | director | A-Award | Acquired | 22,000 | $3.22 |
| 10 Jun 2026 | Bollard Catherine | director | A-Award | Acquired | 22,000 | $3.22 |
| 10 Jun 2026 | Brun Scott C. | director | A-Award | Acquired | 22,000 | $3.22 |
| 2 Mar 2026 | Das Arun | Chief Business Officer | A-Award | Acquired | 175,000 | $3.30 |
| 2 Mar 2026 | Gerard Michael | General Counsel | A-Award | Acquired | 175,000 | $3.30 |
| 2 Mar 2026 | Binder Gwendolyn | President, Science & Tech. | A-Award | Acquired | 225,000 | $3.30 |
| 2 Mar 2026 | Chang David J. | Chief Medical Officer | A-Award | Acquired | 225,000 | $3.30 |
| 2 Mar 2026 | Nichtberger Steven | director, officer: President & CEO | A-Award | Acquired | 674,000 | $3.30 |